SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-006714
Filing Date
2019-12-06
Accepted
2019-12-06 16:03:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a2240232zs-3.htm S-3 182683
2 EX-5.1 a2240232zex-5_1.htm EX-5.1 20561
3 EX-23.1 a2240232zex-23_1.htm EX-23.1 2871
4 G306206.JPG g306206.jpg GRAPHIC 11586
5 G148431.JPG g148431.jpg GRAPHIC 16723
  Complete submission text file 0001047469-19-006714.txt   246571
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235399 | Film No.: 191273114
SIC: 2835 In Vitro & In Vivo Diagnostic Substances